Habitat for Humanity India and Optimus Drugs Private Limited – A Sekhmet Pharmaventures Company Join Hands to Build Homes in Telangana
The partnership provides secure shelter for 26 families living in inadequate housing conditions in Ramalingampally, Bommalaramaram Mandal, Yadadri Bhuvanagiri district of Telangana
Hyderabad, Telangana, 11th September 2024: Habitat for Humanity India, a leading housing non-profit organisation, today announced the handover of 26 new homes in Ramalingampally, Bommalaramaram Mandal, Yadadri Bhuvanagiri district of Telangana in a symbolic dedication ceremony. This project was made possible with the generous support of Mr. Anil Khubchandani, Managing Director and CEO of Optimus Drugs Private Limited - a Sekhmet Pharmaventures Company. The ceremony was attended by Mr. Anand Kumar Bolimera, National Director, Habitat for Humanity India; Officials of Sekhmet Pharmaventures Group; other district officials and local office bearers.
These new homes will provide safe and secure shelter for 26 families located near the Optimus Drugs factory unit in Bommalaramaram Mandal.
Sekhmet Pharmaventures, the holding Company for Optimus Drugs Private Limited and Anjan Drug Private Limited, has a history of collaborating with Habitat for Humanity India on various projects. In Financial Year 2023 (FY23), Habitat India installed 551 household solar lights in Tamil Nadu and Andhra Pradesh with support from Optimus Drugs, while in FY2023 and FY2024, Habitat India repaired 26 homes in Tamil Nadu in a project supported by Anjan Drug Private Limited.
Present during the event, Mr. Anand K. Bolimera, National Director, Habitat for Humanity India said, “We are delighted that 26 families now have an opportunity to lead their life with dignity in their new homes. Habitat for Humanity India's work complements the Government of India's vision of housing for all. We believe that every family deserves a decent place to live, and through our partnership with donors and the community, we are making that vision a reality, one home at a time. We are immensely grateful to Optimus Drugs for their support and commitment to our mission.”
Speaking on the occasion, Ms. G. Uma Rao, CHRO, and Mr. P. N. Baskaran, Chief Operating Officer, Sekhmet Pharmaventures Group, said, “This project embodies our dedication to corporate social responsibility and our commitment to improving the quality of life for communities where we operate in. We are proud to have partnered with Habitat for Humanity India to build homes. These homes will be the foundation of a better future for the families and will enable them achieve strength, stability and self-reliance.”
About Habitat for Humanity India
Driven by the vision that everyone needs a decent place to live, Habitat for Humanity began in 1976 as a grassroots effort. The housing organisation has since grown to become a leading global nonprofit working in more than 70 countries. In India since 1983, Habitat for Humanity has supported more than 38 million people by helping them build or improve a place they can call home, build improved sanitation units and provide humanitarian aid and disaster resilient shelter solutions in the aftermath of natural disasters.
Through financial support, volunteering or adding a voice to support affordable housing, everyone can help families achieve the strength, stability and self-reliance they need to build better lives for themselves. Through shelter, we empower.
To learn more, donate or volunteer, visit www.habitatindia.org
About Optimus Drugs Private Limited - A Sekhmet Pharmaventures Company -
Sekhmet Pharmaventures Private Limited is the Holding Company of Optimus Drugs Private Limited. Optimus is one of the fastest-growing pharmaceutical company with market presence since 2004 in providing the best quality of API, Intermediates & Finished Dosages Formulations in Global market. Their aim from day one has been to provide and ensure better healthcare across the globe through their research, Innovations, affordable products & manufacturing excellence. Optimus was established with a team of scientists who had a passion for chemistry and ensuring better healthcare for everyone. In their journey of two decades, they have developed numerous niche molecules and have emerged as one of the reputed manufacturing companies in the pharma industry. Their determination has driven us from a development lab to a commercial scale Intermediates/ APIs /Finished dosages manufacturing company. Their strength lies in strong process chemistry, process engineering, and focus on R&D which enabled them to meet the global pharma requirements. They believe their human resources are their best competency and are dedicated and determined for the betterment of the organization.
